In mid-October, Baylor Scott & White Medical Center – Temple conducted its 1000th holmium laser enucleation of the prostate (HoLEP), a minimally invasive procedure that can address benign prostatic hyperplasia (BPH). BPH can prevent the bladder from emptying properly and could lead to kidney damage or failure. It also impacts quality of life in about one third of men older than 50 years old.
Your bladder probably isn’t your favorite topic of conversation, but knowing when to talk to your doctor about it is crucial to your health. If you experience frequent and/or painful urination, or you notice blood in your urine, telling your primary care provider is the first step to diagnosing a problem and finding the right care. More often than not, these symptoms are caused by non-life-threatening conditions like urinary tract infection, overactive bladder or, in men, an enlarged prostate. But they also could be symptoms of bladder cancer, the sixth most common form of cancer in the United States.
Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder cancer, many don’t get it. The result, argues a team led by UC Davis Health urologists, is that the disease for many is still as deadly as it was 30 years ago.
Mohit Gupta, MD, has been appointed director of urologic oncology and brings the latest surgical techniques in the treatment of prostate and urinary cancers to NYU Langone Hospital–Brooklyn.